Human Influenza Virus Infection: A Focus on Key Host Determinants Linked to Clinical Disease Severity

Read full text Summarise with VIRAT
Authors: Flora De Conto
Cited by: 0
References: 177

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Influenza viruses remain a major health threat, causing significant illness, death, and high healthcare costs worldwide, despite ongoing research and prevention efforts. A complex interaction between host and viral factors greatly influences the outcomes of influenza infection. Early research mainly focused on the influenza virus's characteristics, but gaining an in-depth understanding of host factors involved in infection helps identify those that may influence disease severity. Notably, as the number of people with one or more comorbidities-that is, conditions that increase the risk of severe influenza-continues to rise, it becomes even more important to investigate the role of host factors. Recognizing host risk factors associated with severe outcomes, mainly caused by excessive inflammatory responses and disruption of epithelial barrier function, is crucial in identifying predictive markers and developing host-based prevention and treatment strategies, especially during pandemics. Moreover, early identification of host risk factors can help reduce severe outcomes and healthcare costs due to hospitalization. To achieve this, detailed analyses of the molecular signature of the host response to influenza virus infection are essential. This review highlights key host factors involved in severe influenza, allowing a better understanding of their roles, especially at the cellular level.

Fields of Study & Subjects

Influenza Virus Research Studies Respiratory viral infections research interferon and immune responses

Publication details

Journal / source
Viruses
Volume
18
Issue
3
Pages
376–376
Publication date
18 March 2026
Language
EN